Kestra Medical closes $148.4M public offering of 6.9M shares at $23.00

KESTRA MEDICAL TECHNOLOGIES, LTD.

Offered 6,900,000 common shares at $23.00 per share, including full exercise of underwriters' over-allotment option of 900,000 shares.
Net proceeds of approximately $148.4 million after underwriting discounts and estimated offering expenses.
Proceeds to support sales/marketing, commercialization, R&D, clinical studies, and working capital.
Underwriters included BofA Securities, Piper Sandler, J.P. Morgan, and Goldman Sachs; offering closed December 4, 2025.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

KESTRA MEDICAL TECHNOLOGIES, LTD. entered into Underwriting Agreement with BofA Securities, Inc., Piper Sandler & Co., J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC, as representatives of the several underwriters named therein valued at approximately $148.4 million (effective 2025-12-02).

Action: entry
Agreement: underwriting
Counterparty: BofA Securities, Inc., Piper Sandler & Co., J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC, as representatives of the several underwriters named therein
Value: approximately $148.4 million
Effective: 2025-12-02

Exact text from the filing

On December 2, 2025, Kestra Medical Technologies, Ltd., a Bermuda exempted company (the “ Company ”) entered into an Underwriting Agreement (the “ Underwriting Agreement ”) with BofA Securities, Inc., Piper Sandler & Co., J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC, as representatives of the several underwriters named therein (collectively, the “ Underwriters ”), related to an underwritten public offering (the “ Offering ”) of 6,900,000 common shares, par value $1.00 per share (the “ Common Shares ”), at a purchase price per share of $23.00 (the “ Offering Price ”).

View on SEC.gov

272 material agreements filed in the last 30 days. Browse all material agreements →

KESTRA MEDICAL TECHNOLOGIES, LTD. filing history →

Source: SEC EDGAR

accession 0001193125-25-308144

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.